SHORT TERM GLYCAEMIC VARIABILITY IN CSII VS MDI IN ADULTS WITH TYPE 1 DIABETES

被引：0
|
作者：
Scott, E. S. [1 ,2 ]
McGrath, R. T. [1 ,3 ]
Januszewski, A. S. [2 ,4 ,5 ]
Fulcher, G. R. [1 ,3 ]
Jenkins, A. J. [2 ,4 ,5 ]
机构：
[1] Royal North Shore Hosp, Dept Endocrinol & Diabet, Sydney, NSW, Australia
[2] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia
[3] Univ Sydney, Northern Clin Sch, Sydney, NSW, Australia
[4] Univ Melbourne, Dept Med St Vincents, Melbourne, Vic, Australia
[5] St Vincents Hosp, Dept Endocrinol & Diabet, Melbourne, Vic, Australia
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
293
引用
收藏
页码：A129 / A130
页数：2
相关论文
共 50 条
  • [41] Metabolic Differences between CSII and MDI in Type 1 Diabetes Mexican Patients from the Multicentric Study RENACED
    Faradji, Raquel N.
    Valenzuela-Lara, Marisol
    Bustamante-Martinez, Jorge F.
    Cecena-Gonzalez, Martha P.
    De la Garza-Hernandez, Natalia E.
    Escobedo-Ortiz, Ana
    Ferreira Hermosillo, Aldo
    Figueroa-Andrade, Mario H.
    Flores-Camargo, Areli
    Garcia-Manzanarez, Raquel
    Gomez-Cruz, Jose R.
    Gonzalez-Galvez, Guillermo
    Islas-Ortega, Laura
    Lopez-Miramontes, Claudia
    Martinez-Ramos, Angelica
    Mendoza-Romo, Miguel A.
    Miracle-Lopez, Sigfrido
    Polanco-Preza, Miguel A.
    Rangel-Guerrero, Hugo G.
    Rodriguez-Sanchez, Ester
    Romero-Zazueta, Alejandro
    Tavera-Hernandez, Marcela
    Valenzuela-Montoya, Julio C.
    Vidrio-Velazquez, Maricela
    Yepez-Rodriguez, Alicia E.
    Nino-Vargas, Ricardo S.
    Sainz De la Maza-Viadero, Maria E.
    Magis-Rodriguez, Carlos
    DIABETES, 2017, 66 : LB33 - LB34
  • [42] Glycaemic variability is associated with oxidative damage independently from glycaemic control in type 1 diabetes
    Dagdelen, S.
    Bahcecioglu, A. B.
    Lay, I.
    Samadi, A.
    Unluturk, U.
    Bayraktar, M.
    DIABETOLOGIA, 2017, 60 : S509 - S509
  • [43] Glycaemic control and diabetes care utilization in young adults with Type 1 diabetes
    Sparud-Lundin, C.
    Ohrn, I.
    Danielson, E.
    Forsander, G.
    DIABETIC MEDICINE, 2008, 25 (08) : 968 - 973
  • [44] Glycemic patterns detected by continuous subcutaneous glucose sensing in children with type 1 diabetes treated by MDI or CSII
    Weintrob, N
    Schechter, A
    Bezaquen, H
    Shalitin, S
    Lilos, P
    Galatzer, A
    Phillip, M
    DIABETES, 2003, 52 : A100 - A100
  • [45] Pregnancy outcome and glycemic control in women with type 1 diabetes: A retrospective comparison between CSII and MDI treatment
    Talaviya, Praful A.
    Saboo, Banshi D.
    Joshi, Shashank R.
    Padhiyar, Jayendra N.
    Chandarana, Hardik K.
    Shah, Smita J.
    Vyas, Chintal K.
    Shah, Asha N.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2013, 7 (02) : 68 - 71
  • [46] RT-CGM in conjunction with CSII vs MDI in optimizing glycaemic control in T1DM: Systemic review and meta-analysis
    William, Jimmy
    McCluskey, Jane
    Gleeson, Nigel
    ENDOCRINOLOGY DIABETES & METABOLISM, 2022, 5 (02)
  • [47] IMPROVED POSTPRANDIAL GLYCAEMIC CONTROL WITH FASTER-ACTING INSULIN ASPART VS INSULIN ASPART IN SUBJECTS WITH TYPE 1 DIABETES USING CSII IN PUMPS
    Bode, B. W.
    Hyveled, L.
    Tamer, S. C.
    Demissie, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A40 - A40
  • [48] CSII vs MDI therapy in childhood and adolescent diabetes: the results of 3 years follow-up
    Emelyanov, Andrey O.
    Kuraeva, Tamara L.
    Peterkova, Valentina A.
    HORMONE RESEARCH, 2009, 72 : 186 - 186
  • [49] Fear of Hypoglycemia in Relatives of Young Type 1 Diabetes Mellitus (T1DM) Patients on MDI and CSII Therapy
    Patrakeeva, Evgenya M.
    Zalevskaya, Alsu G.
    Shlyakhto, Evgeniy V.
    DIABETES, 2014, 63 : A212 - A212
  • [50] SIX MONTHS CSII TREATMENT IMPROVES ARTERIAL STIFFNESS AND ENDOTHELIAL GLYCOCALYX VS MDI INTENSIFICATION IN PATIENTS WITH TYPE 1 DIABETES INDEPENDENTLY OF GLYCEMIC CONTROL.
    Kountouri, A.
    Thymis, J.
    Kousathana, F.
    Balampanis, K.
    Pliouta, L.
    Prentza, V.
    Katogiannis, K.
    Kostelli, G.
    Barmpagianni, A.
    Liatis, S.
    Ikonomidis, I.
    Lambadiari, V.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A153 - A153
12345